Cargando…
Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report
BACKGROUND: Germinal center derived memory B cells and plasma cells constitute, in health and during EBV reactivation, the largest functional EBV reservoir. Hence, by reducing germinal center derived formation of memory B cells and plasma cells, EBV loads may be reduced. Animal and in-vitro models h...
Autores principales: | , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685648/ https://www.ncbi.nlm.nih.gov/pubmed/33228556 http://dx.doi.org/10.1186/s12879-020-05609-z |
_version_ | 1783613218029043712 |
---|---|
author | Assing, Kristian Nielsen, Christian Jakobsen, Marianne Andersen, Charlotte B. Skogstrand, Kristin Gaini, Shahin Preiss, Birgitte Mortensen, Sussi Bagge Skov, Marianne Nielsine Rasmussen, Line Dahlerup |
author_facet | Assing, Kristian Nielsen, Christian Jakobsen, Marianne Andersen, Charlotte B. Skogstrand, Kristin Gaini, Shahin Preiss, Birgitte Mortensen, Sussi Bagge Skov, Marianne Nielsine Rasmussen, Line Dahlerup |
author_sort | Assing, Kristian |
collection | PubMed |
description | BACKGROUND: Germinal center derived memory B cells and plasma cells constitute, in health and during EBV reactivation, the largest functional EBV reservoir. Hence, by reducing germinal center derived formation of memory B cells and plasma cells, EBV loads may be reduced. Animal and in-vitro models have shown that IL-21 can support memory B and plasma cell formation and thereby potentially contribute to EBV persistence. However, IL-21 also displays anti-viral effects, as mice models have shown that CD4(+) T cell produced IL-21 is critical for the differentiation, function and survival of anti-viral CD8(+) T cells able to contain chronic virus infections. CASE PRESENTATION: We present immunological work-up (flow-cytometry, ELISA and genetics) related to a patient suffering from a condition resembling B cell chronic active EBV infection, albeit with moderately elevated EBV copy numbers. No mutations in genes associated with EBV disease, common variable immunodeficiency or pertaining to the IL-21 signaling pathway (including hypermorphic IL-21 mutations) were found. Increased (> 5-fold increase 7 days post-vaccination) CD4(+) T cell produced (p < 0.01) and extracellular IL-21 levels characterized our patient and coexisted with: CD8(+) lymphopenia, B lymphopenia, hypogammaglobulinemia, compromised memory B cell differentiation, absent induction of B-cell lymphoma 6 protein (Bcl-6) dependent peripheral follicular helper T cells (pT(FH), p = 0.01), reduced frequencies of peripheral CD4(+) Bcl-6(+) T cells (p = 0.05), compromised plasmablast differentiation (reduced protein vaccine responses (p < 0.001) as well as reduced Treg frequencies. Supporting IL-21 mediated suppression of pT(FH) formation, pT(FH) and CD4(+) IL-21(+) frequencies were strongly inversely correlated, prior to and after vaccination, in the patient and in controls, Spearman’s rho: − 0.86, p < 0.001. CONCLUSIONS: To the best of our knowledge, this is the first report of elevated CD4(+) IL-21(+) T cell frequencies in human EBV disease. IL-21 overproduction may, apart from driving T cell mediated anti-EBV responses, disrupt germinal center derived memory B cell and plasma cell formation, and thereby contribute to EBV disease control. |
format | Online Article Text |
id | pubmed-7685648 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-76856482020-11-25 Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report Assing, Kristian Nielsen, Christian Jakobsen, Marianne Andersen, Charlotte B. Skogstrand, Kristin Gaini, Shahin Preiss, Birgitte Mortensen, Sussi Bagge Skov, Marianne Nielsine Rasmussen, Line Dahlerup BMC Infect Dis Case Report BACKGROUND: Germinal center derived memory B cells and plasma cells constitute, in health and during EBV reactivation, the largest functional EBV reservoir. Hence, by reducing germinal center derived formation of memory B cells and plasma cells, EBV loads may be reduced. Animal and in-vitro models have shown that IL-21 can support memory B and plasma cell formation and thereby potentially contribute to EBV persistence. However, IL-21 also displays anti-viral effects, as mice models have shown that CD4(+) T cell produced IL-21 is critical for the differentiation, function and survival of anti-viral CD8(+) T cells able to contain chronic virus infections. CASE PRESENTATION: We present immunological work-up (flow-cytometry, ELISA and genetics) related to a patient suffering from a condition resembling B cell chronic active EBV infection, albeit with moderately elevated EBV copy numbers. No mutations in genes associated with EBV disease, common variable immunodeficiency or pertaining to the IL-21 signaling pathway (including hypermorphic IL-21 mutations) were found. Increased (> 5-fold increase 7 days post-vaccination) CD4(+) T cell produced (p < 0.01) and extracellular IL-21 levels characterized our patient and coexisted with: CD8(+) lymphopenia, B lymphopenia, hypogammaglobulinemia, compromised memory B cell differentiation, absent induction of B-cell lymphoma 6 protein (Bcl-6) dependent peripheral follicular helper T cells (pT(FH), p = 0.01), reduced frequencies of peripheral CD4(+) Bcl-6(+) T cells (p = 0.05), compromised plasmablast differentiation (reduced protein vaccine responses (p < 0.001) as well as reduced Treg frequencies. Supporting IL-21 mediated suppression of pT(FH) formation, pT(FH) and CD4(+) IL-21(+) frequencies were strongly inversely correlated, prior to and after vaccination, in the patient and in controls, Spearman’s rho: − 0.86, p < 0.001. CONCLUSIONS: To the best of our knowledge, this is the first report of elevated CD4(+) IL-21(+) T cell frequencies in human EBV disease. IL-21 overproduction may, apart from driving T cell mediated anti-EBV responses, disrupt germinal center derived memory B cell and plasma cell formation, and thereby contribute to EBV disease control. BioMed Central 2020-11-23 /pmc/articles/PMC7685648/ /pubmed/33228556 http://dx.doi.org/10.1186/s12879-020-05609-z Text en © The Author(s) 2020 Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Case Report Assing, Kristian Nielsen, Christian Jakobsen, Marianne Andersen, Charlotte B. Skogstrand, Kristin Gaini, Shahin Preiss, Birgitte Mortensen, Sussi Bagge Skov, Marianne Nielsine Rasmussen, Line Dahlerup Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report |
title | Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report |
title_full | Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report |
title_fullStr | Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report |
title_full_unstemmed | Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report |
title_short | Potential anti-EBV effects associated with elevated interleukin-21 levels: a case report |
title_sort | potential anti-ebv effects associated with elevated interleukin-21 levels: a case report |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7685648/ https://www.ncbi.nlm.nih.gov/pubmed/33228556 http://dx.doi.org/10.1186/s12879-020-05609-z |
work_keys_str_mv | AT assingkristian potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT nielsenchristian potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT jakobsenmarianne potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT andersencharlotteb potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT skogstrandkristin potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT gainishahin potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT preissbirgitte potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT mortensensussibagge potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT skovmariannenielsine potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport AT rasmussenlinedahlerup potentialantiebveffectsassociatedwithelevatedinterleukin21levelsacasereport |